Skip to main content

Table 1 Patient characteristics

From: Time-course of sFlt-1 and VEGF-A release in neutropenic patients with sepsis and septic shock: a prospective study

  Sepsis ¥
(n = 31)
Septic shock
(n = 10)
P
Gender    0.16 **
Male 13 (42%) 7 (70%)  
Female 18 (58%) 3 (30%)  
Age (median, range) 37 (16-55) 55 (24-62) P < 0.01 *
Disease status    0.12 **
Complete remission 13 (42%) 1 (10%)  
Active disease 18 (58%) 9 (90%)  
Treatment    0.48 **
Intensive CTx (includes autologous HSCT) 17 (55%) 6 (60%)  
Allogeneic HSCT 14 (45%) 4 (40%)  
Neutrophils/μl - Fever (median, range) 60 (0 - 290) 50 (20 - 470) 0.40 *
Days of neutropenia (median, range) 12 (4 - 22) 14 (7 - 30) 0.36 *
Platelets ×103/μl - fever (median, range) 25 (6 - 169) 38 (12 - 90) 0.16 *
Days with fever (median, range) 4 (1 - 12) 5 (1 - 12) 0.65 *
SOFA score - fever onset (median, range) 3 (0 - 7) 4 (2 - 8) 0.31 *
SOFA score - 48 hours (median, range) 4 (2 - 7) 7 (4 - 16) P = 0.01 *
MASCC score (median, range) 21 (16 - 23) 18 (11 - 24) P = 0.03 *
Agent isolation in bloodstream    P < 0.001 **
Yes 4 (13%) 8 (80%)  
No 27 (87%) 2 (20%)  
  1. ¥ Non-complicated sepsis; * Mann-Whitney test; ** Fisher's exact test. HSCT: Hematopoietic stem cell transplantation; CTx: chemotherapy.